Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
13 mei 2008 - 08:20
Statutaire naam
Crucell N.V.
Titel
Crucell Announces First Quarter 2008 Results
Bericht
Total revenue and other operating income of €47.9 million, showing 36% growth in the first quarter of 2008 compared to €35.2 million in the same period of 2007.
Net loss in the quarter halved to €9.0 million compared to Q107.
New contracts awarded for Quinvaxem™ and strong sales
in travel vaccines drive autonomous growth.
Gross margin in the first quarter improved to 40% up from 23% last year.
2008 full year guidance reiterated: total revenue and other operating income growth of 20% in constant currencies ; higher margins; positive cash flow.
Datum laatste update: 17 december 2025